CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Asthma Treatments for Acute Asthma in Pediatric Patients: Clinical Effectiveness, Cost Effectiveness, and Guidelines

Last updated: February 26, 2020
Project Number: RB1424-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. ​What is the comparative clinical effectiveness of metered dose inhalers with spacers versus nebulizers for acute asthma treatment?
  2. What is the comparative cost effectiveness of metered dose inhalers with spacers versus nebulizers for acute asthma treatment?
  3. What are the evidence-based guidelines regarding treatments for acute asthma?

Key Message

​Two systematic reviews, and two randomized controlled trials were identified regarding the comparative clinical effectiveness of metered dose inhalers with spacers versus nebulizers for acute asthma treatment. In addition, two evidence-based guidelines were identified regarding treatments for acute asthma. No relevant economic evaluations were identified regarding the comparative cost effectiveness of metered dose inhalers with spacers versus nebulizers for acute asthma treatment.